Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Alzheimer's Medication Trials

San Francisco, California

Alzheimer's medication trials in San Francisco, CA

8 Alzheimer's medication studies are recruiting participants at sites in San Francisco as of November 17, 2026, according to ClinicalTrials.gov. Alzheimer's Medication Trials can help you understand your options and connect with a study team.

Call (888) 927-5916
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

San Francisco at a glance

  • 8 studies are recruiting at a site in San Francisco.
  • By phase: Early Phase 1 (1), Phase 1 (1), Phase 1/2 (2), Phase 2 (2), Phase 3 (2).
  • By sponsor: industry (4), university, hospital or other (4).
  • Most recent update to one of these records: October 26, 2026.

Studies recruiting in San Francisco

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Alzheimer's Tau Platform: Master Protocol

    • Phase 2
    • Ages 50 to 80
    • All sexes
    Sponsor
    Paul S. Aisen
    Study site
    University of California, San Francisco
    Registry record
    NCT06957418 · updated
  2. [18F]PI-2620 Phase 3 Histopathological Study

    • Phase 3
    • Ages 50 and older
    • All sexes
    Sponsor
    Lantheus Biosciences Ltd.
    Study site
    Sutter Health
    Registry record
    NCT05641688 · updated
  3. A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

    • Phase 2
    • Ages 50 to 85
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    UCSF Memory and Aging Center ( Site 1031)
    Registry record
    NCT07033494 · updated
  4. A Study of Psychedelics in Healthy Older Adults With Low Well-being

    • Phase 1
    • Ages 50 to 85
    • All sexes
    Sponsor
    Jennifer Mitchell
    Study site
    University of California San Francisco, Sandler Neuroscience Building
    Registry record
    NCT07386730 · updated
  5. Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eidos Therapeutics, a BridgeBio company
    Study site
    University of California, San Francisco (UCSF)
    Registry record
    NCT06563895 · updated
  6. Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A

    • Early Phase 1
    • Ages 40 to 85
    • All sexes
    Sponsor
    University of Pennsylvania
    Study site
    University of California
    Registry record
    NCT06932809 · updated
  7. Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers

    • Phase 1/2
    • Ages 18 to 80
    • All sexes
    Sponsor
    Ashvattha Therapeutics, Inc.
    Registry record
    NCT05395624 · updated
  8. First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia

    • Phase 1/2
    • Ages 40 to 75
    • All sexes
    Sponsor
    David Wilson
    Study site
    China Basin, UCSF
    Registry record
    NCT05374278 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in San Francisco, CA on ClinicalTrials.gov.

Ask about studies near San Francisco

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in California

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a medication, as each study is coded in the registry.

Alzheimer's Medication Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5916

or send a short form

How should we reach you?

Call